LINEZOLIDE KABI 2 mg/ml, solution for infusion 10 bottles of 300 ml
Active ingredients: Linezolid
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusion10 bottles of 300 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LINEZOLIDE KABI 2 mg/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) polyéthylène basse densité (PEBD) Kabipac de 300 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jan 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69498279CIP75500909CIP133400955009092Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LINÉZOLIDEsolution | 2 mg · 1 ml de solution pour perfusion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.